CAPR
- Capricor Therapeutics, Inc.
()
Overview
Company Summary
Capricor Therapeutics, Inc. is a biotechnology company that specializes in the development and commercialization of innovative cell and gene-based therapies. They primarily focus on creating treatments for diseases that have significant unmet medical needs, particularly in the field of cardiovascular diseases and disorders.
One of Capricor's key areas of expertise is in the development of regenerative medicine therapies using stem cells. Stem cells have the unique ability to differentiate into various types of cells in the body, offering great potential for repairing and regenerating damaged tissues. Capricor is at the forefront of harnessing this potential.
Their leading product candidate is called CAP-1002, which is an investigational allogeneic cell therapy that utilizes donor-derived cardiac cells. It is being developed as a potential treatment for patients who have suffered from a heart attack and subsequent heart failure. CAP-1002 aims to restore cardiac function, reduce scar tissue formation, and improve overall heart health.
Capricor is also researching and developing other cell-based therapies for conditions such as Duchenne muscular dystrophy (DMD), a genetic disorder that causes progressive muscle weakness. Their candidate CAP-2003, which is in preclinical development, focuses on creating a potential treatment for muscle disorders associated with DMD.
In addition to their focus on cell-based therapies, Capricor is exploring the potential of exosome-based technologies. Exosomes are tiny vesicles secreted by cells that play a role in intercellular communication. Capricor's exosome-based platform has the potential to provide therapeutic benefits in several disease areas, including cardiovascular conditions.
Overall, Capricor Therapeutics, Inc. is dedicated to advancing innovative therapies that can address critical unmet medical needs, particularly in cardiovascular diseases and disorders. Through their focus on stem cell and gene-based therapies, they aim to provide patients with effective and potentially life-changing treatments.